Eremid Genomic Services
Eremid Genomic Services is a CLIA-certified, CAP-accredited genomics contract research organization based in Kannapolis, NC, providing multi-platform sequencing, bioinformatics, and clinical genomics services to AgBiotech, Food & Nutrition, and Human Health organizations.
- Company typePrivate
- Founded2019
- HeadquartersKannapolis, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Eremid Genomic Services does
Eremid Genomic Services is a contract research organization (CRO) headquartered at the North Carolina Research Campus in Kannapolis, NC, providing customized genomics research and clinical testing services across three verticals: AgBiotech, Food & Nutrition, and Human Health. The company operates a CLIA-certified (November 2022) and CAP-accredited (November 2023) genomics laboratory equipped with multiple best-in-class sequencing and analysis platforms, including Illumina NovaSeq X+, NextSeq 2000, iSeq 100, and iScan; PacBio Revio for long-read HiFi sequencing; Oxford Nanopore MinION; 10x Genomics Chromium X for single-cell and spatial genomics; Nanostring nCounter for multiplexed expression; and Thermo Fisher GeneTitan for automated microarrays. As a PacBio Certified Service Provider, Eremid offers up to 1,300 human whole genomes per year at 30x coverage following its 2023 Revio installation, supporting applications from de novo assembly and structural variant detection to population-scale clinical studies.
The company's revenue model is project-based contract research, with engagements covering experimental design, sample processing, sequencing, bioinformatics analysis, and final reporting under multi-year contracts at undisclosed custom pricing. Named customers include Immunis AI (large immunogenomic oncology clinical studies) and BCD Biosciences (genomics data delivery). Go-to-market is consultative and direct, supplemented by content marketing, conference presence (ASHG, Precision Health, Plant Genomics & Gene Editing Congress), and partnerships with technology providers including Semaphore Solutions for Labbit LIMS implementation. Eremid is backed by Coddle Creek Capital, which provided a $3 million venture capital round in July 2023 to fund sequencing expansion. Leadership includes Chairman John E. Allen, Jr. (also General Partner of Coddle Creek Capital), CBO Julian Abery, CSO Julien Curaba (PhD, 13+ years research experience), CFO Brian Smith, and Operations Director Becky Borst, with the company employing 11-50 staff.
Eremid Genomic Services firmographics
Firmographics- Name
- Eremid Genomic Services
- Legal name
- Eremid® Genomic Services, LLC
- Website
- https://eremid.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Eremid Genomic Services is a CLIA-certified, CAP-accredited genomics contract research organization based in Kannapolis, NC, providing multi-platform sequencing, bioinformatics, and clinical genomics services to AgBiotech, Food & Nutrition, and Human Health organizations.
- Ownership category
- akta.pro rank
Eremid Genomic Services industry classification
Industry- Product category
- Genomics Contract Research Services
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical and Diagnostic Laboratories (6215), Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071), Services-Health Services (8000)
- akta.pro primary industry
- Genomics & Next-Generation Sequencing (NGS) Services (HLAGANAA)
- akta.pro secondary industries
- Bioinformatics, Multi-Omics Data Analysis & Interpretation Services (HLAGANAI), Genomics & Molecular Diagnostics (Trial Support) (HLAGAEAD), Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD), Transcriptomics & Gene Expression Profiling Services (HLAGANAE), Genomic Testing & Genetic Evaluation Services (AFAEAJAC)
Keywords
Where Eremid Genomic Services is headquartered
LocationHeadquarters
- HQ city
- Kannapolis
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Eremid Genomic Services business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Contract Research Services: Customized contract research services for genomics applications. Projects range from simple to complex studies across AgBiotech, Food & Nutrition, and Human Health sectors. Revenue generated through project-based engagements that include expert consultancy, experimental design, sample processing, data analysis, and project reporting. Pricing tailored to specific scientific needs and scope of work.
- Clinical Genomics Testing: CLIA-certified, CAP-accredited clinical genomics laboratory services. Provides clinical clients with best-in-class genomics analysis, exceptional quality data, and world-class scientific staff for molecular diagnostics development and clinical studies.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom project-based pricing |
Distribution channels1 record
Marketing channels6 records
Eremid Genomic Services product offering
Product offeringCore offering
Eremid Genomic Services is a contract research organization that delivers customized genomics research and clinical testing services from a CLIA-certified, CAP-accredited laboratory in Kannapolis, NC. The company offers tailored sequencing, bioinformatics, and clinical genomics solutions to organizations in AgBiotech, Food & Nutrition, and Human Health sectors, using multi-platform instrumentation including Illumina, PacBio, Oxford Nanopore, 10x Genomics, Nanostring, and Thermo Fisher systems. Services span the full project lifecycle from scientific consultation and experimental design through sample processing, sequencing, bioinformatics analysis, and final project reporting.
Product overview
Eremid Genomic Services is a contract research organization providing customized genomics research and clinical testing services. The company operates a unified service offering centered on its CLIA-certified, CAP-accredited genomics laboratory, which combines advanced sequencing platforms (Illumina NovaSeq X+, NextSeq 2000, iSeq 100, iScan; PacBio Revio; Oxford Nanopore MinION; 10x Genomics Chromium X; Nanostring nCounter; Thermo Fisher GeneTitan) with expert bioinformatics analysis. Services span three specialist sectors—AgBiotech, Food & Nutrition, and Human Health—organized around core capabilities in genomics services, clinical services, and bioinformatics services, all delivered through a six-step process from scientific consultation through to project report.
Differentiator
Problem solved
Functional benefit
Products and services
- Genomics Services Comprehensive genomics laboratory services including Illumina short-read sequencing, PacBio long-read HiFi sequencing, RNA sequencing, epigenetic services, and microbiome sequencing, delivered as customized contract research projects for research organizations.
- Clinical Genomics Services CLIA-certified, CAP-accredited clinical genomics testing services for human health applications, supporting development of molecular diagnostics and clinical studies with regulatory-grade quality data.
- Bioinformatics Services Fully customizable bioinformatics analysis services including de novo or guided genome assembly and finishing, gene model prediction and annotation, and methylation density analysis.
- AgBiotech Research Services Specialized contract research services for agricultural biotechnology organizations, including plant and animal microbiome studies, crop protection research, plant characterization, and trait discovery to support crop research addressing climate change and population expansion.
- Food & Nutrition Research Services Contract research services assessing the impact of foods, supplements, and nutrients on metabolism, including biomarker assessment, influence of diet on health studies, and nutrigenomics research.
- Human Health Research Services Comprehensive human health genomics contract research services including immuno-oncology research, drug discovery and development, molecular diagnostic method development, human microbiome research, cancer research, and pre-clinical population studies.
Quantifiable outcome
- Up to 15-fold increase in long-read sequencing throughput
- +2 more outcomes
Companies that use Eremid Genomic Services
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles3 records
Eremid Genomic Services technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
Eremid Genomic Services partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Semaphore SolutionscoreStrategic partnership for implementation of Labbit LIMS across Eremid's research, clinical, and training labs. Labbit is a next-generation Laboratory Information Management System designed to evolve as science advances, built with FAIR data principles and full data provenance. The partnership advances Eremid's end-to-end clinical genomics services, streamlines workflows, simplifies project management, and enhances collaboration capabilities while aligning with CLIA quality standards.
- PacBiocoreEremid is a PacBio certified service provider offering HiFi sequencing as part of comprehensive genomics and bioinformatics services. Installation of PacBio Revio system provides up to 15-fold increase in long-read sequencing throughput, enabling larger-scale studies and novel applications in clinical genomics and agbiotech. PacBio collaboration enables detection of all types of genetic variations including large structural variants with remarkable precision.
Scale indicators4 records
Recent moves5 records
Expansion highlights6 records
Eremid Genomic Services competitors and assessment
Company assessmentEmerging players
- Daicel Arbor Biosciences: Arbor Biosciences offers targeted sequencing, myTags capture, and PacBio-based services for agbiotech and biomedical customers — comparable in scale and overlapping in long-read, agbiotech, and bioinformatic capabilities.
- Zymo Research: Zymo Research is a niche genomics tools and services provider offering extraction kits, microbiome sequencing, and analysis services for agbiotech and human microbiome customers — comparable to Eremid's microbiome and agbiotech service lines.
Direct peers
- Novogene: Novogene is a leading global genomics CRO with Illumina and PacBio platforms serving academic, agricultural, and clinical customers; comparable multi-platform play with an explicit genomics services focus similar to Eremid.
- LC Sciences: LC Sciences provides NGS, PacBio long-read, single-cell, and bioinformatics services across human health and agricultural research — a closely analogous multi-platform genomics CRO.
- CD Genomics: CD Genomics is an Illumina and PacBio NGS services CRO offering sequencing, bioinformatics, and assembly services to agbiotech and biomedical customers — directly comparable to Eremid's service mix and customer base.
- Azenta Life Sciences (Genewiz): Azenta acquired Genewiz in 2018 and operates the leading multi-platform genomics services business in the US, offering Sanger, NGS (Illumina + PacBio), and synthesis services to pharma and academic customers — directly competing with Eremid's core NGS CRO offering at significantly larger scale.
- Omega Bioservices: Omega Bioservices is a US-based genomics services CRO within the Omega Healthcare group offering NGS, Sanger, and bioinformatics for clinical and research customers — overlapping mid-market positioning with Eremid.
Broad incumbents
- BGI Genomics: BGI operates one of the world's largest sequencing operations (DNBSEQ and others) covering clinical, agricultural, and human health — competes with Eremid across NGS services and bioinformatics at hyperscale.
- NeoGenomics: NeoGenomics is a US clinical oncology and molecular diagnostics lab serving hospital and pharma customers with CLIA/CAP-certified testing — overlaps Eremid's clinical genomics services for pharma/biotech sponsors at much greater scale.
- Eurofins Genomics: Eurofins Genomics is the genomics arm of the global Eurofins testing network, providing NGS, Sanger, oligonucleotides, and bioinformatics across pharma, food, and agbiotech — overlapping with Eremid across all three of its served verticals as a much larger incumbent.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Eremid Genomic Services social profiles
Digital presenceEremid Genomic Services compliance and trust
Trust signalCompliance2 records
Eremid Genomic Services financial estimates
Financial estimateRevenue estimate
Valuation estimate
Eremid Genomic Services leadership team
Management profileNumber of profiles
Profiles5 records
Eremid Genomic Services funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Eremid Genomic Services M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Eremid Genomic Services
What does Eremid Genomic Services do?
Eremid Genomic Services is a contract research organization that delivers customized genomics research and clinical testing services from a CLIA-certified, CAP-accredited laboratory in Kannapolis, NC. The company offers tailored sequencing, bioinformatics, and clinical genomics solutions to organizations in AgBiotech, Food & Nutrition, and Human Health sectors, using multi-platform instrumentation including Illumina, PacBio, Oxford Nanopore, 10x Genomics, Nanostring, and Thermo Fisher systems. Services span the full project lifecycle from scientific consultation and experimental design through sample processing, sequencing, bioinformatics analysis, and final project reporting.
Is Eremid Genomic Services a public or private company?
Eremid Genomic Services is a private company. It is classified as venture growth investor backed and is currently operating.
When was Eremid Genomic Services founded?
Eremid Genomic Services was founded in 2019. It employs 11 to 50 people.
Where is Eremid Genomic Services based?
Eremid Genomic Services is headquartered in Kannapolis, United States, in the North America region.
How does Eremid Genomic Services make money?
Two revenue lines are on record. Contract Research Services are the primary driver. The others are clinical Genomics Testing.
Who are Eremid Genomic Services's main competitors?
Emerging players on record are Daicel Arbor Biosciences and Zymo Research. Direct peers are Novogene, LC Sciences, CD Genomics, Azenta Life Sciences (Genewiz) and Omega Bioservices. Broad incumbents are BGI Genomics, NeoGenomics and Eurofins Genomics.
Does Eremid Genomic Services have an API?
No public API is recorded for Eremid Genomic Services.
What industry is Eremid Genomic Services in?
Eremid Genomic Services's product category is Genomics Contract Research Services. Its primary akta.pro industry code is HLAGANAA, Genomics & Next-Generation Sequencing (NGS) Services, with a secondary code of HLAGANAI, Bioinformatics, Multi-Omics Data Analysis & Interpretation Services. Its NAICS code is 541714 and its SIC code is 8731.